Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
DarioHealth Corp
DRIO | US
7.50
USD-0.10
-1.32%
DRIO | US
Loading StockChartView...
About DarioHealth Corp
Sector
Healthcare
Industry
Diagnostics & Research
Earnings date
30/06/2024
As of date
05/06/2026
Close
7.50
Open
7.42
High
7.53
Low
7.40
DarioHealth Corp. operates as a digital therapeutics company in the United States Canada the European Union Australia and New Zealand. The company offers Dario Evolve a metabolic solution to address metabolic health needs such as diabetes hypertension and weight management; Dario Move which helps to prevent and treat the most common MSK conditions; Dario Elevate a behavioral health solution that optimizes access to evidence-based care; Dario One a full suite of chronic condition management solutions; DarioEngage platform; and Dario blood glucose monitoring system. It also provides smart glucose meters; bluetooth connected blood pressure cuff; digital scales; biofeedback sensor devices; and Dario smart diabetes management solutions including live clinical coaching content automated journeys hardware and lifestyle coaching. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York New York.
View LessDRIO | US
Risk
55.8
Sharpe
-0.49
Luna's Score
36/100
Recommendation
Sell
Luna says (DRIO | US)
What's Working
Value Stock (Price to Book < 3)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
41.3%1 month
55.8%3 months
69.7%6 months
78.5%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
0.45
Debt to equity
0.45
Debt to assets
0.25
Ent. to EBITDA
-0.59
Ent. to rev.
2.02
PEG
-
Other Fundamentals
EBITDA
-57.96M
MarketCap
225.21M
MarketCap(USD)
225.21M
Div. yield
-
Op. margin
-258.85
Erngs. growth
-
Rev. growth
1.70
Ret. on equity
-69.37
Short ratio
15.00
Short perc.
6.60
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
1.15
Range1M
1.84
Range3M
3.62
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.66
Price X volume
37.74K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -0.59 | 12.67 | Cheaper |
| Ent. to Revenue | 2.02 | 44.00 | Cheaper |
| PE Ratio | - | 40.09 | - |
| Price to Book | 0.45 | 77.50 | Cheaper |
| Dividend Yield | - | 1.18 | - |
| Std. Deviation (3M) | 69.73 | 59.59 | Par |
| Debt to Equity | 0.45 | -14.36 | Expensive |
| Debt to Assets | 0.25 | 0.34 | Cheaper |
| Market Cap | 225.21M | 13.71B | Emerging |
